It was also recently observed that the anthocyaninidin, cyanidin, modulates inflammatory responses through decreasing expression of toll-like receptor 4 (TLR4), which lies upstream of NF-κB activation, in neuroblastoma cells treated with amyloid beta protein. The gene discussed is NFKB1; the disease is neuroblastoma.